Randomized Phase-III Study on HIPEC in Ovarian Cancer Impact on Patient Management

被引：0
|
作者：
Meier, W. [1 ]
机构：
[1] Univ Frauenklin Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany
来源：
ONKOLOGE | 2018年 / 24卷 / 09期
关键词：
PRIMARY SURGERY; CHEMOTHERAPY;
D O I：
10.1007/s00761-018-0424-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [21] Ovarian Cancer - The Impact of Pelvic Ultrasound Quality on the Management of Patients with Suspected Ovarian Cancer: A Randomized Controlled Study
    Yazbek, J.
    Raju, S. K.
    Ben-Nagi, J.
    Holland, T. K.
    Hillaby, K.
    Jurkovic, D.
    IMAGERIE DE LA FEMME, 2008, 18 (02) : 139 - 140
  • [22] Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer
    Graham, Radha
    MacDonald, Nicola D.
    Mould, Tim A.
    Kotsopoulos, Ioannis C.
    OBSTETRICIAN & GYNAECOLOGIST, 2024, 26 (02): : 76 - 83
  • [23] MULTICENTRIC RANDOMIZED PHASE-III STUDY ON ADJUVANT TREATMENT OF OPERABLE CERVICAL-CARCINOMA
    KNAPSTEIN, PG
    MAINZ, R
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 691 - 693
  • [24] RANDOMIZED PHASE-III TRIAL OF CHEMO-IMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-III, OPTIMAL DISEASE OVARIAN-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    ALBERTS, DS
    MASONLIDDIL, N
    OTOOLE, RV
    ABBOTT, TM
    KRONMAL, R
    HILGERS, RD
    SURWIT, EA
    EYRE, HJ
    BAKER, LH
    GYNECOLOGIC ONCOLOGY, 1989, 32 (01) : 16 - 21
  • [25] Combining HIPEC to Interval Surgery in Ovarian Cancer? One Step Forward with a Second Randomized Study: Comment on “Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer—A Phase 3 Clinical Trial”
    B. Noiret
    N. Bakrin
    C. Eveno
    Annals of Surgical Oncology, 2022, 29 : 3357 - 3358
  • [26] Carbogen and nicotinamide in locally advanced bladder cancer: Early results of a phase-III randomized trial
    Hoskin, Peter J.
    Rojas, Ana M.
    Saunders, Michele I.
    Bentzen, S. M.
    Motohashi, K. J.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 (01) : 120 - 125
  • [27] EPIRUBICIN OR EPIRUBICIN AND VINDESINE IN ADVANCED BREAST-CANCER - A PHASE-III STUDY
    NIELSEN, D
    DOMBERNOWSKY, P
    SKOVSGAARD, T
    JENSEN, J
    ANDERSEN, E
    ENGELHOLM, SA
    HANSEN, M
    ANNALS OF ONCOLOGY, 1990, 1 (04) : 275 - 280
  • [28] NEUTRON THERAPY IN CERVICAL-CANCER - RESULTS OF A PHASE-III RTOG STUDY
    MAOR, MH
    GILLESPIE, BW
    PETERS, LJ
    WAMBERSIE, A
    GRIFFIN, TW
    THOMAS, FJ
    COHEN, L
    CONNER, N
    GARDNER, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (05): : 885 - 891
  • [29] HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) A PROMISING TREATMENT FOR RELAPSED INTRAPERITONEAL OVARIAN CANCER. AN ONGOING PHASE III, EUROPEAN MULTICENTRIC RANDOMIZED TRIAL
    Classe, J. M.
    Meeus, P.
    Ray-Coquard, I.
    Quenet, F.
    Berton-Rigaud, D.
    Leblanc, E.
    Gladieff, L.
    Lorimier, G.
    Ferron, G.
    Houvenaeghel, G.
    Gouy, S.
    Marchal, F.
    Baranger, B.
    Lecuru, F.
    Pocard, M.
    Guyon, F.
    Durand-Fontanier, S.
    Torrent, J.
    Stanbury, T.
    Glehen, O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1319 - 1320
  • [30] Impact of HIPEC introduction in cytoreduction for ovarian cancer of ovarian origin: a real-world population study
    Mendez, Blanca Valenzuela
    Quenet, Francois
    Thezenas, Simon
    Carrere, Sebastien
    Maurregot, Anne
    Sgarbura, Olivia
    Colombo, Pierre-Emmanuel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A423 - A424
12345